agence france-presse
click here to return to agence france-presse main menu
DonateNow



AIDS: Swiss report on sex stirs controversy at conference

Agence France-Presse - August 3, 2008
Christine Courcol

MEXICO CITY, Aug 3, 2008 (AFP) - Swiss researchers were welcomed with cheers but also tough questions here Sunday as they suggested that patients with HIV whose infection is curbed by drugs do not pass on the virus during unprotected sex.

Their presentation, on the opening day of the world AIDS conference, came under challenge from some delegates, who feared it could encourage unsafe sex, but most attending the debate seemed to give a warm welcome.

In January, **Switzerland's Federal Commission for HIV/AIDS issued a report on so-called "discordant" couples -- couples in which one individual has HIV while the other does not.

The panel said that such couples need not use a condom provided the infected partner regularly followed antiretroviral therapy and had no genital infections.

In addition, the level of human immunodeficiency virus (HIV) in his or her blood had to be below detectable levels -- a threshold of 40 viruses per milliliter of blood -- for the six previous months at least.

In a debate just ahead of the 17th International AIDS Conference, panel member Pietro Vernazza said there was "no documented case" of infection among discordant couples who fell in this category, and characterised the risk of transmission as "negligible."

He also pointed out that sex without using a condom -- the sole recommended method for practising safe sex -- was an "issue of pleasure."

Health experts, policymakers and field workers attended the event, and some openly challenged the findings.

"This message is too broad. People will think it's OK not to use condoms any more," said Rolande Hodel, who heads a non-govenmental organisation called AidsfreeAfrica.

Nancy Padian, a researcher at North Carolina University, said the report was of "limited applicability" in poor countries and had "a large potential for doing more harm than good."

But Nikos Dedes, with the European AIDS Treatment Group, congratulated the Swiss team, saying the report "lifts the fear of being a threat to partners" and helped regain the right to the "uninhibited experience of sexual pleasure."

In a paper published by The Lancet last month, epidemiologists led by David Wilson of the University of New South Wales in Sydney used a simple mathematical model to estimate the cumulative risk of transmission if the infected partner had only 10 viruses per millilitre of blood.

Their model is based on the assumption that each couple has 100 unprotected sexual encounters a year.

If so, an HIV-negative male would face a 0.22-percent risk of infection each year from an HIV-positive woman. The risk for an uninfected female from an infected male would be 0.43-percent annually.

The risk in gay relationships would be far higher -- in male-to-male anal transmission the probability of infection would be 4.3 percent per year.

Extrapolated over a decade, this would translate into a fourfold increase in AIDS infections among discordant couples, compared with current rates of condom use.

"If the claim of non-infectiousness in effectively treated patients was widely accepted, and condom use subsequently declined, then there is the potential for substantial increases in HIV incidence," the study warned.

The antiretroviral drug "cocktail," introduced in 1996, has been a lifesaver for many people with HIV.

But it is not a cure, for it only suppresses viral levels, rather than eradicate the pathogen completely. If the drugs are stopped, the virus rebounds.


**Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle

**HIV-infected persons on effective antiretroviral therapy (and free of other STDs) are sexually non-infectious

**HIV-infizierte Menschen ohne andere STD sind unter wirksamer antiretroviraler Therapie sexuell nicht infektiös

080803
AF080816


Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.